|
|
|
|
|
01.04.26 - 13:03
|
Bruker Announces Appointment of Thierry Bernard to its Board of Directors (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience.
Frank H. Laukien, the Chairman, President and CEO of Bruker Corporation, stated: “Bruker is delighted that Thierry is joining our Board. I have admired his successful track record, astute strategic initiatives, and outstanding execution for many years, and I am convinced that Thierry will be an excellent addition to our Board of Directors as we further develop our leadership position in life-science research, biopharma, and diagnostic solutions in the post-genomic era, and aim for profitable growth and rapid margin expansion to enhance stakeholder value.”
Mr. Bernard currently serves as Chief Executive Officer of QIAGEN N.V. He joined QIAGEN in 2015 to l...
|
|
|
|
|
|
|
|
|
|
|
13.02.26 - 22:09
|
Forecasting The Future: 15 Analyst Projections For Bruker (Benzinga)
|
|
|
Latest Ratings for BRKR
DateFirmActionFromTo Feb 2022SVB LeerinkMaintainsOutperform Nov 2021Wells FargoMaintainsEqual-Weight Sep 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for BRKR
View the Latest Analyst Ratings
Importance Rank:
1
read more...
|
|
|
|
|
|
|
|
|
|
|
12.02.26 - 16:00
|
Bruker (BRKR) Q4 Earnings Miss Estimates (Zacks)
|
|
|
Bruker (BRKR) delivered earnings and revenue surprises of -9.23% and +1.12%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
12.02.26 - 13:06
|
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
|
|
|
Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically
Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted EPS of $0.59
FY25 revenues of $3.44 billion, up ~2% yoy, down ~4% organically
FY25 GAAP diluted loss per share of $(0.15); non-GAAP diluted EPS of $1.83
Bruker initiates FY26 guidance:
Revenues of $3.57 to $3.60 billion, up 4% to 5% yoy, with organic growth of 1% to 2%
Non-GAAP EPS of $2.10 to $2.15, up 15% to 17% yoy, including an ~8% FX headwind
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025.
Frank H. Laukien, Bruker's President and CEO, commented: “At the conclusion of a difficult year 2025, with headwinds from academic funding, tariffs and currencies, we are pleased that in the fourth quarter we delivered revenues ahead of our expectations. A recovery in biopharma and industrial research markets in the second hal...
|
|
|
|
|
05.02.26 - 22:09
|
Bruker Announces Quarterly Preferred Stock Dividend (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock Dividend”). The Mandatory Convertible Preferred Stock Dividend will be paid on March 2, 2026 to stockholders of record as of February 15, 2026.
About Bruker Corporation – Leader of the Post-Genomic Era
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved...
|
|
|
|
|
05.02.26 - 14:03
|
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast (Business Wire)
|
|
|
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2025 Earnings Webcast” hyperlink in the “Events & Presentations” section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702 (international) and referencing “Bruker's Fourth Quarter 2025 Earnings Conference Call”.
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
